MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not

44Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The prognostic significance of single-nucleotide polymorphisms (SNPs) and tumour protein levels of MMP-2 and MMP-9 was evaluated in 215 colorectal cancer patients. Single-nucleotide polymorphism MMP-2-1306T and high MMP-2 levels were significantly associated with worse survival. Extreme tumour MMP-9 levels were associated with poor prognosis but SNP MMP-9-1562C>T was not. Tumour MMP levels were not determined by their SNP genotypes. © 2008 Cancer Research.

Cite

CITATION STYLE

APA

Langers, A. M. J., Sier, C. F. M., Hawinkels, L. J. A. C., Kubben, F. J. G. M., Van Duijn, W., Van Der Reijden, J. J., … Verspaget, H. W. (2008). MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not. British Journal of Cancer, 98(11), 1820–1823. https://doi.org/10.1038/sj.bjc.6604380

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free